Precigen Ownership | Who Owns Precigen?

Overview Forecast RevenueFinancials Chart Transcripts

Precigen Ownership Summary

Precigen is owned by 29.89% institutional investors, 10.17% insiders, and 59.94% retail investors. Patient capital management is the largest institutional shareholder, holding 7.29% of PGEN shares. Patient Opportunity C is the top mutual fund, with 4.92% of its assets in Precigen shares.

PGEN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Precigen	29.89%	10.17%	59.94%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Patient capital management	18.17M	7.29%	$28.72M
Blackrock	10.25M	4.11%	$16.19M
Vanguard group	6.76M	2.71%	$10.68M
Geode capital management	3.10M	1.24%	$4.89M
State street	2.84M	1.14%	$4.49M
Iridian asset management llc/ct	2.07M	0.83%	$3.27M
D. e. shaw	1.73M	0.69%	$2.73M
Renaissance	1.18M	0.47%	$1.87M
Charles schwab investment management	1.10M	0.44%	$1.73M
Jpmorgan chase	1.08M	0.43%	$1.70M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Patient capital management	18.17M	1.53%	$28.72M
Iridian asset management llc/ct	2.07M	0.74%	$3.27M
Emfo	519.48K	0.73%	$820.77K
Fore capital	206.81K	0.21%	$326.76K
Sanders morris harris	559.50K	0.15%	$884.01K
Lexaurum advisors	241.19K	0.09%	$381.08K
Clarivest asset management	492.15K	0.08%	$777.60K
Msd partners	355.00K	0.05%	$560.90K
American financial group	66.11K	0.04%	$104.00K
Chiron capital management	27.85K	0.04%	$44.00K

Top Buyers

Holder	Shares	% Assets	Change
Patient capital management	18.17M	1.53%	721.20K
Gmt capital	668.83K	0.04%	668.83K
Lexaurum advisors	241.19K	0.09%	152.02K
Renaissance	1.18M	0.00%	130.50K
Advisor group	408.33K	0.00%	109.69K

Top Sellers

Holder	Shares	% Assets	Change
Millennium management	141.93K	0.00%	-1.23M
Opaleye management	-	-	-947.50K
Jpmorgan chase	1.08M	0.00%	-215.91K
Sanders morris harris	559.50K	0.15%	-145.50K
Blackrock	10.25M	0.00%	-116.07K

New Positions

Holder	Shares	% Assets	Change	Value
Gmt capital	668.83K	0.04%	668.83K	$1.06M
Corebridge financial	68.10K	0.00%	68.10K	$107.60K
Mirae asset global etfs	66.71K	0.00%	66.71K	$105.40K
Clearstead advisors	20.60K	0.00%	20.60K	$32.55K
Mirae asset global investments	7.54K	0.00%	7.54K	$11.38K

Sold Out

Holder	Change
Farther finance advisors	-78.00
Eversource wealth advisors	-93.00
Innealta capital	-99.00
Sound income strategies	-890.00
Federation des caisses desjardins du quebec	-900.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	132	-2.22%	75,430,370	24.15%	29	5.16%	54	-6.90%	31	-20.51%
Jun 30, 2024	133	-0.75%	60,750,666	-1.85%	24	3.95%	58	26.09%	39	-15.22%
Mar 31, 2024	134	-3.60%	61,894,662	-1.03%	24	3.80%	46	-13.21%	46	6.98%
Dec 31, 2023	139	-2.11%	62,537,683	3.31%	25	4.31%	53	-1.85%	43	10.26%
Sep 30, 2023	142	-	60,532,127	5.49%	24	4.55%	54	20.00%	39	-13.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Patient Opportunity C	14.40M	4.92%	-99.79K
Vanguard Total Stock Mkt Idx Inv	5.45M	1.86%	-
iShares Russell 2000 ETF	3.36M	1.15%	-7.56K
Vanguard Institutional Extnd Mkt Idx Tr	1.91M	0.65%	-
Fidelity Small Cap Index	1.31M	0.45%	-13.38K
iShares Russell 2000 Value ETF	1.09M	0.37%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	914.71K	0.31%	-26.00K
Fidelity Extended Market Index	864.49K	0.30%	104.70K
iShares Biotechnology ETF	820.97K	0.28%	-4.91K
JPM Thematics Genetic Thrps C2 Acc USD	777.30K	0.27%	-23.26K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 09, 2024	Perez Jeffrey Thomas	SVP, IP Affairs	Buy	$50.00K
Aug 09, 2024	KIRK RANDAL J		Buy	$20.00M
Dec 28, 2023	KIRK RANDAL J		Buy	$136.33K
Dec 28, 2023	KINDLER JEFFREY B	-	Sell	$136.33K
Sep 22, 2023	MITCHELL DEAN J	-	Buy	$35.25K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	1	1
2023 Q3	7	20

PGEN Ownership FAQ

Who Owns Precigen?

Precigen shareholders are primarily institutional investors at 29.89%, followed by 10.17% insiders and 59.94% retail investors. The average institutional ownership in Precigen's industry, Biotech Stocks , is 47.04%, which Precigen falls below.

Who owns the most shares of Precigen?

Precigen’s largest shareholders are Patient capital management (18.17M shares, 7.29%), Blackrock (10.25M shares, 4.11%), and Vanguard group (6.76M shares, 2.71%). Together, they hold 14.12% of Precigen’s total shares outstanding.

Does Blackrock own Precigen?

Yes, BlackRock owns 4.11% of Precigen, totaling 10.25M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.19M$. In the last quarter, BlackRock decreased its holdings by -116K shares, a -1.12% change.

Who is Precigen’s biggest shareholder by percentage of total assets invested?

Patient capital management is Precigen’s biggest shareholder by percentage of total assets invested, with 1.53% of its assets in 18.17M Precigen shares, valued at 28.72M$.

Who is the top mutual fund holder of Precigen shares?

Patient Opportunity C is the top mutual fund holder of Precigen shares, with 4.92% of its total shares outstanding invested in 14.4M Precigen shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools